Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Biogen, one of the worlds first global biotechnology companies, owns a patent to develop an Alzheimers disease treatment. It is considering building a new medicine

Biogen, one of the worlds first global biotechnology companies, owns a patent to develop an Alzheimers disease treatment. It is considering building a new medicine production facility in Raleigh, NC to produce active pharmaceutical ingredients for Alzheimer medicine. It is estimated that the new medicine production facility would cost $300 million to build. The new facility will produce the treatment with a 3-month course of treatment priced at $10,000. The cost to produce the medicine per treatment is $3000. The company expects that 10,000 patients per year forever will use the treatment. For convenience of discussion, assume the cost to build the new medicine production facility will stay the same as well as the number of patients to get the treatments every year will stay the same forever. However, there is fierce competition in the Alzheimer drug market. The competition causes an uncertain drug price next year. Suppose a 3-month course of treatment will be either $20,000 per treatment or $4,000 per treatment next year with equal probability. The risk-free rate is 10% per year and that is also the cost of capital (Ignore taxes)

a. What is the NPV to invest today? (sample answer: $350.50 million)

b. Calculate the expected NPV of the project if postponed by one year? (sample answer: $350.50 million)

c. Calculate the value of the option to postpone the building of the new facility by one year. (sample answer: $350.50 million)

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image_2

Step: 3

blur-text-image_3

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Mergers And Acquisitions A Study Of Financial Performance Motives And Corporate Governance

Authors: Neelam Rani , Surendra Singh Yadav, Pramod Kumar Jain

1st Edition

981102202X,9811022038

More Books

Students also viewed these Finance questions